Company profile
Nextleaf Solutions Ltd.
OTC: OILFF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#657 of 1,422 Healthcare companies by revenue31st-percentile growth
EA Score
57CFH 64DQ —GM 45SS 39
v0.1 · 45/100 weight · provisional
↑ return on assets, net margin · ↓ Piotroski F, growth stability
Methodology →Revenue TTM
$7.4M
Rev growth YoY (TTM)
-15.4%
Net income (FY)
-$116.7k
Employees
26
as of 2026-08-23
Market cap
$4.6M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$8.1M11.3M CAD2025
Net income-$116.7k-163.2k CAD2025
Operating income-$243.1k-340.0k CAD2025
Total assets$5.6M7.8M CAD2025
Liabilities$2.3M3.3M CAD2025
Equity$3.3M4.6M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Nextleaf Solutions Ltd.’s revenue?
Nextleaf Solutions Ltd. booked $8.1M in FY2025 revenue, contracting 12% year over year — slower than 69% of Healthcare companies we track, at a -1.4% net margin.
Peers · Healthcare
Aspyra Inc.——Nuwellis, Inc.43DSolid Biosciences Inc.41DCoya Therapeutics, Inc.48DCogent Biosciences, Inc.48DAclaris Therapeutics, Inc.47DKey facts
CEOEmma Andrews
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: OILFF
Employees26
IPO date2019-04-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.